Pharmaceutical preparations for the prevention and treatment of cancer, inflammation and inflammatory diseases, auto-immune diseases, ophthalmic diseases, angiogenesis-dependent diseases, ocular angiogenic disease, diabetic retinopathy and macular degeneration made in whole or significant part of tyrosine kinase inhibitors